MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. DISPOSABLE ELECTROSURGICAL SNARE

Model Number SD-210U-25

Device Problem Adverse Event Without Identified Device or Use Problem (2993)

Patient Problems Abdominal Pain (1685); Fever (1858); Pancreatitis (4481)

Event Date 01/31/2023

Event Type  Injury  

Manufacturer Narrative

The device was not returned to olympus for evaluation.Doi.Org/10.1371/journal.Pone.0282899 provided for additional information.The investigation is ongoing, and a supplemental report will be submitted upon completion of the investigation or if any additional information is provided.

Event Description

Olympus received the literature titled "efficacy and safety of novel hemostatic gel in endoscopic sphincterotomy or endoscopic papillectomy: a multicenter, randomized controlled clinical trial." background: endoscopists often experience obstacles with traditional hemostasis using the side-viewing duodenoscope for bleeding after endoscopic sphincterotomy (est) or endoscopic papillectomy (ep).Aims: in this randomized controlled trial, we evaluated the efficacy and safety of a novel hemostatic gel for post-est or post-ep bleeding.Methods: a randomized trial was conducted from november 2020 to december 2021 at two tertiary centers in south korea.Patients who experienced bleeding immediately after est or ep were enrolled in the study, and primary hemostasis was achieved with either the novel hemostatic gel or epinephrine spray.Results: a total of 84 patients were enrolled in this study, and 41 patients were finally analyzed in each group.Hemostatic gel was significantly superior to epinephrine spray for successful primary hemostasis (100% vs.85.4%; p = 0.026).).In terms of delayed bleeding, no significant difference was observed between the hemostatic gel and epinephrine spray (2.4% vs.7.3%; p = 0.329).The mean procedural time was significantly higher for the hemostatic gel than epinephrine spray (3.23 ±1.94 vs.1.76 ±0.99 min; p < 0.001), and no differences were observed in the adverse events.Conclusions: the novel hemostatic gel is expected to achieve satisfactory results with easier hemostasis for immediate bleeding after est or ep.Adverse events suspected to be associated with the procedure were 14.6% in the epinephrine group and 7.3% in the cggel group, with no significant differences.There were three cases of abdominal pain and three cases of pancreatitis in the epinephrine group.Two patients suffering from fever and one case of pancreatitis were observed in the cggel group.All these cases were evaluated as mild to moderate severity aes, and all events improved with conservative management.Type of adverse events/number of patients: abdominal pain (3) fever (2) pancreatitis (4) this report is related to the following patient identifiers: (b)(6) (evis lucera duodenovideoscope / tjf-260v) (b)(6) (disposable electrosurgical snare / sd-210u-25) this medwatch is for (b)(6).

Event Description

An olympus device did not cause or contribute to the adverse events described in the article.Also, it was confirmed that there was no malfunction of an olympus device.

Manufacturer Narrative

This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.This supplemental report includes additional information received from the author.B5 updated accordingly.Olympus will continue to monitor field performance for this device.

• Brand Name: DISPOSABLE ELECTROSURGICAL SNARE
• Type of Device: DISPOSABLE ELECTROSURGICAL SNARE
• Manufacturer (Section D): AOMORI OLYMPUS CO., LTD.; 2-248-1 okkonoki; kuroishi-shi, aomori 036-0 357; JA 036-0357
• Manufacturer (Section G): AOMORI OLYMPUS CO., LTD.; 2-248-1 okkonoki; kuroishi-shi, aomori
• Manufacturer Contact: todd brill ; 800 west park drive; westborough, MA 01581 ; 5082077661
• MDR Report Key: 18650580
• MDR Text Key: 334723020
• Report Number: 9614641-2024-00283
• Device Sequence Number: 1
• Product Code: FDI
• Combination Product (y/n): N
• Reporter Country Code: KS
• PMA/PMN Number: K902735
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Other,Foreign,Study,Literature,Health Professional,Company Representative
• Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date: 03/15/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 02/06/2024
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Device Model Number: SD-210U-25
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Date Manufacturer Received: 03/15/2024
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Treatment: (EVIS LUCERA DUODENOVIDEOSCOPE / TJF-260V)
• Patient Outcome(s): Other